Journal list menu
- Author Formatting
- Titles and Abstracts
- English Language
- Author Information
- Overall Formatting
- Details of Style
- Clinical Trials
- Institutional Review Board
- Manuscript Text
- Review Criteria
- Conflict of Interest
- Scientific Misconduct
- JOR Pre-Print Policy
- JOR Data Sharing Policy
Visit the new Author Services today! Features include:
- Free access to your article for 10 of your colleagues; each author of a paper may nominate up to 10 colleagues. This feature is retrospective—even articles already published offer this feature for free colleague access.
- Access in perpetuity to your published article.
- Production tracking for your article with optional e-mail alerts
- A list of your favorite journals with quick links to the Editorial Board, Aims & Scope, Author Guidelines and if applicable the Online Submission website; journals in which you have tracked production of an article are automatically added to your Favorites.
- Guidelines on optimizing your article for maximum discoverability.
JOR Early-Career Award
This award highlights the work of an early-career researcher to enhance the awardee's professional profile. A grant award of $2000 will be presented to a single recipient at the ORS Annual Meeting, selected by the Editors from eligible papers accepted by the Journal of Orthopaedic Research in the prior calendar year.
Candidate must be an Assistant Professor (or equivalent) within 10 years of completion of terminal research degree.
Candidate must be a member of the ORS in good standing.
Candidate must be the Lead author on the submitted paper. (The work must clearly be that of the applicant and not that of any co-author.)
Potential candidates must indicate a desire to compete by checking the JOR Early-Career Award box during the online submission process. The applicant's professional credentials and eligibility must be outlined in the cover letter that accompanies the submission. Upon acceptance of their manuscript, applicant will be asked to submit a full curriculum vitae as well as a letter of endorsement from his/her department chair.
This award is sponsored by Wiley on behalf of the Journal of Orthopaedic Research.
Graphical Abstracts: JOR is excited to offer Graphical Abstracts! See Manuscript Preparation below for details on how to submit a graphical abstract with your manuscript.
Required Submission Forms
Authors submitting to JOR must include any of the below required forms that are relevant to their manuscripts.
Institutional Review Board / Animal Care and Use Committee approval: Manuscripts that describe experimental work using human or animal subjects must include approval from an Institutional Review Board or an Institutional Animal Care and Use Committee, obtained prior to performing the study. Authors must submit a copy of approval papers as a supplemental file.
ARRIVE Checklist: Authors describing experimental work using live animals must submit a completed ARRIVE (Animals in Research: Reporting In Vivo Experiments) Checklist with their manuscript. The Checklist must be submitted if the animals were alive at any point during the study. The ARRIVE Checklist can be downloaded as a PDF fillable form or a Microsoft Word document. Please download and save the form to your computer before you fill it out; changes will not be saved in an internet browser.
Permission to re-use: Authors who need to secure permission to re-use tables, figures, or other text and materials from previously published works can use this standard Permission Request Form.
To contact the Editorial Office, please write to the Managing Editor, Shantaya Brinson, at [email protected].
Articles considered by Journal of Orthopaedic Research: Journal of Orthopaedic Research is the forum for the rapid publication of high quality reports of new information on the full spectrum of orthopaedic research, integrating life sciences, engineering, clinical and translational studies. We consider for publication Research Articles, Review Articles, Perspectives Review Articles, Letters to the Editor, and Society News.
The Journal accepts Research Article manuscripts reporting original research only. Studies should include some element of basic science. Levels of Evidence IV and V will not be considered. Case reports will not be considered. Letters to the Editor must be in response to a published article.
Review Articles. The journal invites Review Articles, and will also consider proposals for unsolicited Review Article manuscripts. Authors of unsolicited Reviews must query the editorial office with an abstract, outline, and all author information; approved Reviews will be issued an invitation to submit. Review Articles are subject to the same length restrictions as Research Articles. Meta-analysis and systematic reviews should be submitted as Research Articles.
Perspectives Review Articles, (Invited). A Perspectives Review is submitted from two or more labs working together to offer more than one perspective. The meetings of the Orthopaedic Research Society (ORS) provide a worldwide forum for the presentation and discussion of important advances in musculoskeletal research. Critical components are spotlight and workshop sessions focused on emerging research that has the potential to change clinical practice. These sessions bring together outstanding investigators from a wide variety of scientific disciplines. Recognizing the importance of the sessions for promoting innovative musculoskeletal research, the Journal of Orthopaedic Research Editorial Advisory Board and the journal editors invite review articles based on the ORS workshops and spotlight sessions as well as other selected topics presented at the ORS meetings. The purpose of these articles is to place in perspective important research developments and directions. (See the Editors' Editorial regarding Perspectives: http://onlinelibrary.wiley.com/doi/10.1002/jor.21391/pdf) The invited reviews will focus on specific topics that will be of broad interest to ORS members and all of those engaged in musculoskeletal research. The reviews will be concise, and the editors will ensure that these reviews are published as soon as possible after the meetings. Unsolicited Perspectives Review manuscripts may be rejected without peer review at the discretion of the Editors.
Journal of Orthopaedic Research is pleased to offer authors web-based submission and peer-review.
Submit your manuscripts online using our ScholarOne Manuscript Central site http://mc.manuscriptcentral.com/jores. If you do not already have an account, please click the "Create an Account" button. After you have created your account, you can submit your article for consideration. At the end of a successful submission, a confirmation screen with a manuscript number will appear, and you will receive an email confirming that the manuscript has been received by the journal. Through your Author Center on this website, you can view the status of your manuscripts as they progress through the review process. Notification of the disposition of each manuscript will be sent by email to the corresponding author on the day of decision.
Submission Fee The Journal of Orthopaedic Research charges a standard fee of $50.00 US for all unsolicited nonmember submissions with the exception of revised manuscripts, invited reviews and commentaries, and Letters to the Editor. This fee covers expenses for the processing and evaluation of your submission by office staff and Editors. External peer review is not guaranteed by payment of the submission fee. Orthopaedic Research Society (ORS) members are not subject to submission fees. The submitting author does not have to be a member; if any co-author of the paper is an active member of the ORS, the submitting author may select Member article.
Manuscripts that do not adhere to the below instructions WILL BE RETURNED to the corresponding author for correction before being sent out for peer review.
Useful information for writing your manuscript is available in: Wright TM, Hayes WC, Buckwalter JA: Writing for the Journal of Orthopaedic Research. J Orthop Res 17:459-468, 1999.
Author Formatting. Journal of Orthopaedic Research is pleased to offer an Author Formatted submission option. Tables and figures may be embedded smoothly and closely into the flow of text for a quicker review. If your tables and figures are not suitable for this style, please use the more traditional submission style of submitting tables and figures in separate files. Authors of accepted papers will be expected to provide table and figure files to the production-level specifications outlined in the below instructions. All other guidelines must be adhered to in Author Formatted submissions.
Titles and Abstracts. As you prepare your manuscript, please consider how best to optimize your visibility in search engines by following these tips for titles and abstracts:
Be succinct: 16 words or less, with the most important words first and last. Use MeSH terms (http://www.nlm.nih.gov/mesh/).
Use only commonly accepted acronyms.
Use active voice.
Mention the organism studied; use the most common names for gene, organism, etc.
Mention the technique if it is the primary focus.
If you state that X affects Y, include the affect.
Don’t use a question or complete sentence.
Ask yourself: Can you tweet it? Does your title clearly reflect the content?
Be concise, succinct, descriptive, and engaging.
Include synonyms for words and concepts that are in the title.
Focus on 3-4 keyword phrases and use throughout.
Ask yourself: What terms would you use when searching for your article?
For more information on Search Engine Optimization, please visit Wiley's website: http://authorservices.wiley.com/bauthor/seo.asp.
English Language: All manuscripts must be written in clear, correct English. Authors whose “first” language is not English should arrange for their manuscripts to be written in idiomatic English before submission. The text should also be carefully checked for errors. Please visit the following page on Wiley's Author Services site for language editing resources http://authorservices.wiley.com/bauthor/english_language.asp
Author Information: The submitting author should be prepared to list all co-authors electronically in the system. Existing accounts can be searched by email address. New accounts must be created using a valid email address unique to each author.
Overall formatting: Manuscripts must be submitted in .doc or .rtf file format, using standard 8.5 x 11 inch (21 x 28 cm) paper with at least 1 inch (2.5 cm) margins on all sides. All text must be Times New Roman font, size 12 point, with double-spaced lines and a ragged right margin. Please do not use any text linking, such as for references, as this sort of formatting causes errors when text is displayed for review.
Details of Style: The Editors reserve the right to adjust style to certain standards of uniformity. For matters of style, follow the Scientific Style and Format: The CBE Manual for Authors, Editors, and Publishers (6th edition), published by Cambridge University Press. Keep abbreviations to the minimum, and define each at its first use. Do not use acronyms or abbreviations in the abstract. For reference to the sources of equipment or supplies, use a generic description to refer to the item in the body of the text, followed by the model number, vendor name, city, and state or country, enclosed in parentheses: e.g., electrohydraulic materials test system (model 1331; Instron, Canton, MA). If a trade name is used for a drug, provide the name of the generic along with the manufacturer's information. Abbreviations and units of measurement should all be in SI units. Sufficient detail should be provided that the experiments can be reproduced.
Clinical Trials must be registered with https://clinicaltrials.gov/ and authors must provide confirmation of registration in their manuscript or as a supplemental file. All clinical trials started after January 1, 2016 must prospectively registered at https://clinicaltrials.gov/ or a similar database recognized by the ICMJE to be considered for publication. See list of ICMJE acceptable registries at http://www.icmje.org/ about-icmje/faqs/clinical-trials-registration/. The original study protocol for all registered clinical trials must be included and can be uploaded as a supplemental file.
Institutional Review Board / Animal Care and Use Committee approval: Manuscripts that describe experimental work using human or animal subjects must include approval from an Institutional Review Board or an Institutional Animal Care and Use Committee, obtained prior to performing the study. Authors must submit a copy of approval papers as a supplemental file.
Research and Review Articles are restricted to 4,200 words of body text (Introduction through Discussion/Conclusion). Title page, abstract and keywords, references, and legends are not considered in the word count. Perspectives Review articles have no length restriction.
The text of a Research Article should be organized as follows: Title page, Abstract, Introduction, Methods, Results, Discussion, Acknowledgments, References, Tables, and Figure legends. Pages should be numbered in succession, the title page being page 1, and all lines should be numbered.
The text of a Review Article or a Perspectives Review Article should be organized as follows: Title Page; Abstract; Introduction explaining and defining the topic and its importance; Body of the manuscript organized according to the author's preference, but including concise summaries of the information presented at the workshop or spotlight session; Conclusion section defining the important unanswered questions related to the topic and providing clear directions for future research related to the topic; Acknowledgments; References; Tables; and Figure legends.
Title page: The title page should be the first page of the manuscript text document and provide the following: Full article title. Full name of each author, with affiliation. Full name, address, telephone and fax numbers, and e-mail address of the corresponding author (to whom proofs and reprint requests should be addressed). Running title of 5 words or less. Author Contributions Statement. Any necessary footnotes to these items.
Author Contributions Statement: Credit for authorship should be based on:  substantial contributions to research design, or the acquisition, analysis or interpretation of data;  drafting the paper or revising it critically;  approval of the submitted and final versions. All title pages must include a brief description of each authors' contribution and a statement that all authors have read and approved the final submitted manuscript.
Corresponding author: Corresponding author should take responsibility for communicating with all other authors and getting their approval for the final version to be published.
Abstract and Keywords. On the page following the title page, please provide an unstructured abstract of up to 250 words, a single paragraph describing the purpose, methods, results, and conclusions of the study. Where applicable, the abstract should include a labeled Statement of Clinical Significance. Authors should also supply up to five keywords suitable for indexing. Keywords may be modified by the Editors.
Methods: For studies involving human subjects, authors should identify the type of study and level of evidence at the beginning of the Methods Section (Levels of Evidence IV and V will not be considered). Manuscripts that describe experimental work using human or animal subjects must include a statement in the Methods section that approval was obtained from an Institutional Review Board or an Institutional Animal Care and Use Committee prior to performing the study. Authors must perform appropriate and rigorous statistical analysis.
Clinical Trials must be registered with https://clinicaltrials.gov/. Authors must provide confirmation of registration in their manuscript or as a supplemental file.
Institutional Review Board / Animal Care and Use Committee approval: Authors must submit a copy of approval papers as a supplemental file.
Acknowledgments: In the acknowledgments, the authors must: (1) identify the sources of all funding for the study including internal sources; and (2) provide information concerning all of the authors' professional and financial affiliations that may be perceived to have biased the presentation.
References: A full list of all publications cited in the text should be provided in numerical order, sequentially as they appear in the text. Do not alphabetize. The titles of journals should be abbreviated as in Index Medicus. If there are four or fewer authors, they should all be listed; if there are five or more, the first three authors should be listed, followed by et al. Double-space the reference list. The reference list should not exceed 50 papers. References should take the following form:
Journal Article (issue published)
Mackay D, Wood L, Rangan A. 2000. The treatment of isolated ulnar fractures in adults: a systematic review. Injury 31: 565–573.
Journal Article (epub ahead of print)
Norambuena GA, Patel R, Karau M, et al. 2016. Antibacterial and Biocompatible Titanium-Copper Oxide Coating May Be a Potential Strategy to Reduce Periprosthetic Infection: An In Vitro Study. Clin Orthop Relat Res. [Epub ahead of print].
Journal Article (web only, no volume/issue)
Odekerken JCE, Welting TJM, Arts JJC, Walenkamp GHIM, Emans PJ. 2013. Modern Orthopaedic Implant Coatings — Their Pro’s, Con’s and Evaluation Methods, Modern Surface Engineering Treatments, Dr. M. Aliofkhazraei (Ed.), InTech, DOI: 10.5772/55976. Available from: http://www.intechopen.com/books/modern-surface-engineering-treatments/modern-orthopaedic-implant-coatings-their-pro-s-con-s-and-evaluation-methods.
Journal Article (in press)
Brown JE. The relation between citations and references. J Med Style. In press.
Chapter in a Book
Richards RR, Corley FG. 1996. Fractures of the shafts of the radius and ulna. In: Rockwood CA Jr, Green DP, Bucholz RW, et al., editors. Fractures in adults, 4th ed. Philadelphia: Lippincott; p 120–134.
Rockwood CA Jr, Green DP, Bucholz RW, et al. 1996. Fractures in adults, 4th ed. Philadelphia: Lippincott; 234 p.
If your manuscript has been accepted for publication and it becomes necessary to add a reference after your article has been typeset, the reference should be placed at the end of the reference list. Do not renumber all the references and all the citations in the text to reflect the correct location of the citation. Simply cite the reference where needed in the text, but use the last number plus one in the existing reference list.
Figure Legends: Figure legends should be concise descriptions of the figures. Type figure legends double-spaced on a page separate from the text and tables. Provide one legend for each figure, and number legends in sequence. For photomicrographs, indicate the stain used and include a size marker (scale bar) on the image.
Tables: Tables must be typed, created using the tables function in a word processing program, and provided as text in .doc or .rtf file format. Each table should begin at the top of a new page (tables should not share pages with other tables or other manuscript text). Each table must have a self-explanatory title, be numbered in order of appearance with Arabic numerals, and be cited in the text. A table should have a legend or notes when appropriate. Tables should only be used for data that cannot be included in the written text and should not duplicate material in the text or figures. Tables should be as small as possible and should not exceed one standard-sized manuscript page. (Tables exceeding one standard-sized manuscript page must be submitted as Supplementary Material. See below.)
Figures: Authors may submit figures in PDF or .doc(x) files for review. Figures must be clear and readable in the system-rendered HTML or PDF for review. Authors of accepted papers will be expected to provide figure files to the production-level specifications outlined in the below instructions.
To ensure publication of high-quality figures, when preparing digital art, please submit figures in separate .tif or .eps file formats, with the following attributes for the output size of the file:
CMYK format for color figures
300 DPI/PPI for picture-only figure files, in grey-scale or color
600 DPI/PPI for figures containing pictures and line elements (i.e., text labels, thin lines, arrows, etc.)
1200 DPI/PPI for black and white images such as line drawings, graphs, or charts (bitmapped line art)
We recommend creating your graphics, with all fonts and scale bars included, using Photoshop or Illustrator and then uploading the figure files into Manuscript Central. File formats that are NOT acceptable are JPG/JPEG, GIF, ONG, PCX, PNG, XBM, PDFs, PowerPoint, Word, and Excel.
Creating, Sizing and Labeling Figures: Authors should prepare figures so that they can be printed in the smallest size consistent with conveying essential information. Figures should be submitted as electronic images to fit either one column (82.5 mm) or as a series of images that fill part or a full-page width (169 mm). The vertical length of an illustration cannot exceed 228 mm. Final figure size is at the discretion of the journal. All scaling, cropping, and rotating should be performed by the authors to minimize white space prior to submission. It is essential that figures be cropped to focus only on the area of interest. An example of this would be, if a figure is demonstrating a repair of the femoral head, it would not be appropriate to include the entire femur in the image.
Helvetica typeface is preferred for lettering of figures. To ensure clarity of presentation, all letters, numbers and symbols in the figure must be a single size, which will reduce to no less than 2 mm high (in the published figure) and be contained within the boundaries of the figure . All figures, when appropriate, must contain a scale bar (within the boundary of the figure itself) to show the final magnification.
The Journal prefers that authors use line drawings rather than photographs of cadaveric material or experimental animals. Photographs of human subjects are acceptable if the authors have received appropriate permission for publication of the photographs or taken appropriate measures to disguise the individual's identity.
Figures should be numbered by the order they are referenced in the text. If a figure consists of several images this should be noted with consecutive letters (e.g., Figure 1a, 1b, etc). Please do not embed figure numbers or component letters in the images; indicate figure numbers in figure file names (e.g., Figure 1.tif, Figure 2a-d.eps). Abbreviations used in figures and legends must match exactly those used in the text. Each figure should have a title and a brief descriptive legend (see Figure Legends above); results should not be repeated in the legend. The publisher reserves the right to regroup illustrations and change their size and position to utilize pages efficiently.
Please select LWZ compression (an option in the "save" process of programs such as Photoshop) when saving your figures. This is a lossless compression routine that reduces the size of your figures without compromising their quality.
Previously Published Figures and Tables: If an author wishes to include Figures and Tables that have been previously published, they must cite the previous publication and secure permission from the copyright holder. A template permissions letter can be found here: http://authorservices.wiley.com/bauthor/author.asp. Please include permissions for re-used figures and tables at time of manuscript submission.
Color Charge Policy: Color images are reproduced for free in the online version of an article with grayscale reproduction in print. Print reproduction of color images is at cost to the author of $500 per figure.
Graphical Abstract: Authors are encouraged to submit abstracts in graphical form. To submit a graphical abstract, prepare a .doc file which includes the article title, the authors' names (with the corresponding author indicated by an asterisk), and an 80-words abstract summarizing the key findings presented in the paper. The .doc must be accompanied by a figure from the manuscript that best represents the scope of the paper. The supplied image (e.g. tiff, eps, jpeg, file formats) should be re-scaled to fit within the dimensions of 50mm x 60mm and have a minimum resolution of 300 dpi. (Please avoid graphs and other figures with fine detail due to the relatively small size of this image.) The .doc file and figure file should be entitled ‘Graphical Abstract’ and uploaded to ScholarOne Manuscript (S1M) during the manuscript submission process. (Please note, graphical abstract will be published at the discretion of the editors.)
Cover Photos: Submission of potential cover photos is encouraged; upon submission, these should be uploaded as a supplemental figure entitled, “for consideration as a cover photo”. A minimum resolution of 300 dpi size of 8.5 × 11” is required for consideration. Images must look good on a white background.
Supplementary Material: Authors are encouraged to submit supplementary material that could aid readers in understanding the authors' findings and where appropriate to ensure that the length restrictions are met. Supplementary material for articles published in the Journal of Orthopaedic Research will be available in the online version of the journal. This accompanying information may include (but is not limited to) figures, tables, video clips, large sections of movies (.mov, .mpeg, .mpg4, .avi, .wav, and .wmv), data sets, program code, and electronic graphical files. Supplementary material must be submitted at the time of peer review, although the reviewers and editors may also suggest that figures or table(s) be provided as supplementary material during the review process. Each piece of supplementary material should be referenced within the text (e.g. Figure 1 is primary, and Figure S-1 is supplementary). Please note that supplementary material is NOT edited by the publisher after final acceptance by the editors, and is posted online in the format in which it is supplied. Supplementary material is available online with published articles to licensed subscribers.
Submitting a Revision: Please make every effort to return a requested revision within the two-month deadline. Requests for deadline extension will be considered. Revised papers must be accompanied by a clean revised text (primary file), a marked revised text (supplemental file), and a detailed response to reviewer comments (authors should respond to each individual comment, including both the comments and responses in the system field provided).
Review Criteria. Criteria for acceptance of a manuscript for publication include outstanding quality and originality of the research, excellence in the writing and organization of the manuscript, and the priority and potential impact of the manuscript to readers of the Journal of Orthopaedic Research . Manuscripts must, therefore, not only be technically competent, but also significantly impact orthopaedic research.
All submitted manuscripts are reviewed initially by the Editors for quality, novelty, scientific importance, and relevance to the journal's general readership. Manuscripts with insufficient priority for publication or those that are outside the scope of the journal are not reviewed further, and are returned to the authors. Manuscripts judged worthy of further consideration are sent to Deputy Editors for assignment of referees.
Manuscripts will be reviewed by peer experts chosen by the editors and/or suggested by the authors. The editors make every effort to have reviews returned within two weeks. If the reviewers provide comments and suggestions and recommend that a revised manuscript be resubmitted for review, authors will have two months to return a revision. If the deadline is exceeded, it will be viewed as a new submission requiring new, initial reviews. This policy is intended to avoid long delays in resubmission and to ensure publication of high quality, timely orthopaedic research. Requests for deadline extensions will be considered.
Reviewers. Authors should submit the names, institutional affiliations, and e-mail addresses of three reviewers who have the necessary expertise to evaluate the submitted manuscript. The editorial office has the responsibility of assigning reviewers but will take into consideration the individuals named by the authors.
Conflict of Interest Disclosure.The purpose of this policy is to provide readers of your manuscript with information about your other interests that could influence how they receive and understand your work. We ask that you err on the side of full disclosure; it is better to disclose a relationship than not to do so.
The Journal of Orthopaedic Research and Wiley require that all authors disclose any potential sources of conflict of interest. Any interest or relationship, financial or otherwise, that might be perceived as influencing an author’s objectivity is considered a potential source of conflict of interest. These must be disclosed when directly relevant or indirectly related to the work that the authors describe in their manuscript. Potential sources of conflict of interest include but are not limited to: Board membership, Consultancy, Employment, Grants/grants pending, Patents (planned, pending, or issued), Royalties, Stock/Stock Options, Speaker’s fees, and/or payment for development of educational presentations.
The existence of a conflict of interest does not preclude publication in this journal. If the authors have no conflict of interest to declare, they must also state this at submission.
It is the responsibility of the corresponding author to review this policy with all authors and to collectively list in the cover letter to the Editor-in-Chief, in the manuscript (under the Acknowledgment section), and in the online submission system ALL pertinent commercial and other relationships.
Scientific Misconduct. The editors of the Journal of Orthopaedic Researchstrongly condemn all forms of scientific misconduct. New submissions are actively scrutinized for signs of misconduct and all allegations are taken seriously. The Journal will investigate any suspicion of misconduct and, if proof of misconduct is discovered, notify the corresponding author's institution and funding agencies. Additionally, the Journal will not consider publication of any papers by the offending authors for at least one year, subject to the editors' judgment of the severity of the case.
The Journal of Orthopaedic Research adheres to the definitions and guidelines of the Committee on Publication Ethics (COPE). Scientific misconduct includes, but is not limited to the following:
Data falsification: fabrication, omission, or distortion of data.
Plagiarism: appropriation of language, data, or ideas without due credit.
Self-plagiarism, redundancy, or duplicate publication: publication of an article that significantly overlaps with another the author(s) published previously. This may be accomplished by reusing the same data with similar findings, implementing superficial changes to disguise the similarity between the two articles, or publishing the same article in two different languages.
Journal of Orthopaedic Research uses a plagiarism detection system. By submitting your manuscript to us, you agree that your manuscript may be screened for plagiarism against previously published works.
Authorship issues: improperly assigning credit by excluding legitimate authors or including authors who did not significantly contribute to the research, submitting a multi-authored paper without consent of all authors; failing to fully disclose funding or conflicts of interest.
Deviation from standard research practices or legislative and regulatory requirements: including but not limited to use of funds, care of animals , human subjects or tissues, drugs, devices, or radioactive, biological or chemical materials.
Image manipulation: enhancing, obscuring, moving, removing, or introducing a specific element of an image is considered data falsification. Adjustments that affect the whole image (e.g., brightness or contrast) are generally acceptable provided all data from the original image are still present. All image modifications must be noted in the figure legend.
Committee on Publication Ethics (COPE). 1999. Guidelines on Good Publication Practice. http://publicationethics.org/static/1999/1999pdf13.pdf
Graf C. et al. 2007. Best Practice Guildelines on Publication Ethics: A Publisher's Perspective. Int J Clin Pract 61: 1-26. http://doi.wiley.com/10.1111/j.1742-1241.2006.01230.x
Nakamura, Y. and Christensen, N.B. 2009. Plagiarism. Cancer Sci 100:1563-1565.http://doi.wiley.com/10.1111/j.1349-7006.2009.01254.x
JOR will not accept clinical research manuscript submissions—which we define as research involving human subjects or their medical records—that have been posted to preprint servers prior to submission, and we will withdraw from consideration any papers posted to those servers prior to publication. We exempt from this policy all laboratory research that does not involve human subjects, and we recommit ourselves to offering fast-track publication to those papers that share time-sensitive messages pertaining to patient health or safety.
Excluding the aforementioned clinical research submissions, JOR will consider for review articles previously available as preprints on non-commercial servers such as ArXiv, bioRxiv, psyArXiv, SocArXiv, engrXiv, etc. Authors may also post the submitted version of their manuscript to non-commercial servers at any time. Authors are requested to update any pre-publication versions with a link to the final published article.
JOR encourages Data Sharing via deposition of the data to a public repository at the authors’ expense. JOR authors are encouraged to include access information in their papers.
If your paper is accepted, the author identified as the formal corresponding author for the paper will receive an email prompting them to login into Author Services; where via the Wiley Author Licensing Service (WALS) they will be able to complete the license agreement on behalf of all authors on the paper.
For authors signing the copyright transfer agreement:
If the Open Access option is not selected the corresponding author will be presented with the copyright transfer agreement (CTA) to sign. The terms and conditions of the CTA can be previewed in the samples associated with the Copyright FAQs below:
CTA Terms and Conditions http://authorservices.wiley.com/bauthor/faqs_copyright.asp
For authors choosing Open Access:
If the Open Access option is selected the corresponding author will have a choice of the following Creative Commons License Open Access Agreements (OAA):
Creative Commons Attribution License OAA
Creative Commons Attribution Non-Commercial License OAA
Creative Commons Attribution Non-Commercial -NoDerivs License OAA
To preview the terms and conditions of these open access agreements please visit the Copyright FAQs hosted on Wiley Author Services http://authorservices.wiley.com/bauthor/faqs_copyright.asp and visit http://www.wileyopenaccess.com/details/content/12f25db4c87/Copyright--License.html
If you select the Open Access option and your research is funded by The Wellcome Trust and members of the Research Councils UK (RCUK) you will be given the opportunity to publish your article under a CC-BY license supporting you in complying with Wellcome Trust and Research Councils UK requirements. For more information on this policy and the Journal’s compliant self-archiving policy please visit: http://www.wiley.com/go/funderstatement.
Proofs must be reviewed within 48 hours of receipt; late return may cause a delay in publication of an article. Please check text, tables, legends, and references carefully. To expedite publication, page proofs rather than galleys will be sent electronically to the author. Return proofs via the online proof system
Reprints may be purchased at https://caesar.sheridan.com/reprints/redir.php?pub=10089&acro=jor.